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Abstract 
As anesthesia providers, the early detection and treatment of myocardial ischemia is 
crucial in reducing the patients postoperative mortality related to cardiac complications. Heart 
disease continues to be the leading cause of death in the United States. Delivering anesthesia to 
patients in the operating room with increased risk factors for cardiovascular disease requires 
increased vigilance, an advanced knowledge of the disease process and the monitoring tools 
available to the anesthetist for the earliest detection of myocardial ischemia. The ECG monitor 
has been used for decades in the operating room to monitor the heart rate of patients, but by 
assessing the ST segment of the ECG we can more specifically monitor the heart for ischemia. 
The purpose of this Independent Project is to provide a thorough and comprehensive review of 
the latest literature related to the use of continuous ST segment monitoring in the operating 
room.  An expansive literature review was completed through the University of North Dakota’s 
Harley E. French Library of Health Sciences. The literature provided current information on how 
ECG patch placement and lead selection can impact the accuracy and sensitivity of early ST 
segment changes.  It also provided valuable information about the relationship between 
tachycardia and ST segment changes and how the duration of ST segment changes can impact 
the postoperative complication of myocardial infarction.  The ability of the anesthetist to 
accurately utilize the features of continuous ST segment monitoring can be an invaluable tool in 
the prevention of postoperative complications. 
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Continuous ST segment monitoring in the Operating Room 
Background 
 Coronary artery disease remains the leading cause of death among both men and women 
in the United States (Porth & Matfin, 2009).  Patients who carry multiple risk factors for 
coronary artery disease (CAD) can suffer from myocardial ischemia anytime when coronary 
oxygen demand exceeds supply. Risk factors for CAD include: race, male gender, age greater 
than 65y/o, hyperlipidemia, hypertension, cigarette smoking, diabetes mellitus, obesity and 
family history of premature development of CAD (Hines & Marschall, 2008). Traditionally 
practitioners have relied on patients to express symptoms of myocardial ischemia, such as chest 
pain, as the first warning sign.  Identifying perioperative myocardial ischemia can be difficult 
because the anesthetized or sedated patient may not be able to express symptoms. Cardiac 
complications are the most common cause of post-operative morbidity and mortality, with the 
30-day mortality rate exceeding 2% in moderate to high risk non-cardiac surgery (Landesberg et 
al., 2009).             
There are multiple monitoring devices that can be used in the operating room to detect 
myocardial ischemia including transesophageal echocardiography, pulmonary capillary wedge 
pressures and electrocardiography (ECG). ECG is the most inexpensive, noninvasive and 
technically simple to operate. ECG has been routinely used in the operating room for decades, 
and is a standard of care for monitoring all patients receiving anesthesia (Nagelhout & Plaus, 
2014).  The ECG displays a continual tracing of the electrical activity of the heart from patches 
strategically placed on the chest.  The ST segment of the ECG can be diagnostic for myocardial 
ischemia or infarction if there is elevation or depression from the patient’s baseline (Shanewise, 
2006).  Visual detection of ST segment changes has not been shown to be reliable, and thus one 
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of the advancements in ECG monitoring is the ability of the monitor software to set a baseline 
when the patient is initially connected and automatically, in real time, track the ST segment for 
changes (Shanewise, 2006). Alarms can be set to notify the anesthetist if changes exceed a 
predetermined elevation or depression. Proper use of this technology can be a very important 
monitoring strategy for early detection of intraoperative myocardial ischemia for patients that 
have increased risk factors for CAD or are undergoing a high risk surgery (Shanewise, 2006). 
Case Report 
 The case being reviewed involved a 69 year old female with a history of renal cell 
carcinoma presenting for a right open, radical nephrectomy for a urinary fistula after partial 
nephrectomy. The patient’s height was 4’10 and weight was 76kg. She was categorized as an 
ASA 3 and had allergies to Keflex, Morphine, Bactrim and Sulfa. Past medical history included 
asthma, hypertension, dyslipidemia, diabetes type 2, atrial fibrillation with prior partial 
nephrectomy, and chronic pain. Surgical history included a cholecystectomy, lumpectomy, 
lithotripsy, cystoscopy, shoulder/knee and hip surgery.  The patient reported no personal or 
family history of anesthetic complications.  Current medication regimen included Norvasc, baby 
Aspirin, Lisinopril, Amoxicillin, Xanax, Flexeril, Levothyroxine, Glucophage, and Zocor.  A 
thorough preoperative examination included vital signs which were as follows: blood pressure 
134/73, heart rate 90, respiratory rate 16, oxygen saturation 95% and a temperature of 97.9.  
Laboratory data included a complete blood cell count noting a hemoglobin of 11.5 g/dl, 
hematocrit 35.4 g/dl, and platelet count of 419 per mm^3. A complete metabolic panel was 
within normal limits and an elevated hemoglobin A1C of 6.1. No coagulation studies were 
completed. A pre-operative ECG was completed and demonstrated normal sinus rhythm with no 
ST segment abnormalities and an echocardiogram showed an ejection fraction of 65%, mild 
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(grade 1) diastolic failure, mild LV hypertrophy, no wall motion abnormalities or valvular issues 
were noted. She was referred pre-operatively for a cardiology consultation and clearance for 
surgery. Her consultation note addressed the fact that the patient’s METs was less than 4 with 
fatigue being her predominant symptom and she was classified as an intermediate cardiovascular 
risk due to her multiple risk factors and the proposed surgery. No further pre-operative studies 
were recommended. The patient was not able to be started on a beta blocker because of prior 
bradycardia. She was cleared for surgery.  
 When the patient entered the operating room, the standard monitors were placed 
including a 5-lead ECG.  The patches were placed in the normal position on the chest, with the V 
lead (brown) placed in the V5 position (5th intercostal space, half way between the midclavicular 
line and the mid axillary line). Continuous ST segment monitoring was initiated, a baseline J 
point was established for the 7 leads displayed and an ECG strip was printed prior to induction.  
Her airway assessment included a Mallampati I, normal thyromental distance, normal 
inter-incisor distance and full range of motion of her neck.  After pre-oxygenation, induction 
medications were given as follows: fentanyl 100mcg, propofol 150mg and rocuronium 50mg.  
The patient was intubated with a 7.0 ETT using a MAC 3 blade.  Correct placement was 
confirmed with bilateral breath sounds and presence of an end tidal carbon dioxide wave form.  
The endotracheal tube was taped and secured while the patient was placed on volume control 
ventilation with a tidal volume of 550ml, rate of 12, positive end expiratory pressure of 5cm 
H2O with an inspiratory pressure ranging around 20cm H2O.  Sevoflurane 2% was used as the 
inhalational anesthetic. An arterial line was started in the left radial artery with a good waveform 
and an additional 18G IV was started in the forearm.   
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 Prior to incision the patient was given 1250mg of Vancomycin, 1 gram of Ofirmev and 
100mcg of fentanyl.  During the case the patient was given an additional 200mcg of fentanyl for 
analgesia and re-dosed three times with 10mg rocuronium to maintain 2/4 twitches.  The case 
lasted three hours and was complicated by an increased blood loss to total 1100ml.  The patient 
was given a total of 2500ml of lactated ringers and 500ml albumin. A hemoglobin was rechecked 
after the first 500mls of blood loss and resulted at 8.8 g/dl.  The patient was cross matched for 2 
units of RBCs and were administered prior to the end of the case.  The patient’s vital signs 
remained relatively stable throughout the case, only requiring 300mcg of phenylephrine to keep 
her BP within 20% of her normal.  She remained sinus rhythm and her ST segments only 
deviated 0.1-0.3mm from the baseline throughout the case.   
 At the end of the procedure, muscle relaxants were reversed with 0.6mg glycopyrolate 
and 3mg neostigmine.  Anti-emetics included Decadron 4mg and Zofran 4 mg.  The patient was 
extubated awake without complications and placed on 4L O2 per nasal cannula. In the recovery 
room she denied any pain or nausea.  The patient’s hemoglobin the next day was 10.5 g/dl, she 
was discharged home 4 days later without complications.  
Discussion 
Coronary Heart Disease  
Epidemiology  
In 2010, the overall death rate attributed to cardiovascular disease had decreased by 31% 
compared to 2000 but the overall burden of disease has remained high. (American Heart 
Association). The total direct/indirect cost for care related to cardiovascular disease and stroke 
was estimated at $315.4 billion, compared to 201.5 billion for cancer care. It is the most 
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expensive of all diagnostic groups (AHA, 2014). According to the American College of 
Cardiology and the American Heart Association (ACC/AHA) the prevalence of coronary artery 
disease increases with age. The population over the age of 65, is the fastest growing age group, 
and is estimated to grow 25-35% over the next 30 years (2007).  “Thus, it is conceivable that the 
number of non-cardiac surgical procedures performed in older persons will increase from the 
current 6 million to nearly 12 million per year, and nearly one fourth of these—major intra-
abdominal, thoracic, vascular, and orthopedic procedures—have been associated with significant 
perioperative cardiovascular morbidity and mortality” (ACC/AHA, 2007, p.162).   
Risk Factors  
There are numerous risk factors that contribute to the development of coronary artery 
disease including: male gender, increasing age, hyperlipidemia, hypertension, cigarette smoking, 
obesity, diabetes mellitus, sedentary lifestyle, family history and even psychological factors such 
as stress and having a type A personality (Hines & Marschall, 2008).  As part of its 2020 Impact 
Goals, the American Heart Association is trending data on seven “health metrics” it believes are 
reflective of cardiovascular health.  These metrics are smoking, body mass index, physical 
activity, healthy diet, total cholesterol, blood pressure and fasting plasma glucose (2014).  Due to 
the broad range of risk factors that can contribute to coronary artery disease, there have been 
multiple risk calculators developed to try and assist the anesthetist in predicting pre-operative 
risk. 
 The 2014 ACC/AHA perioperative guidelines highlight estimating this risk based on a 
combination of both clinical risk factors and the surgical procedure being performed. For patients 
with risk factors for stable coronary artery disease, the ACC/AHA recommended the use of the 
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Revised Cardiac Risk Index (RCRI) or the National Surgical Quality Improvement Program 
(NSQIP) risk calculator (ACC/AHA, 2014). The NSQIP was developed by the American 
College of Surgeons and uses 20 patient predictors combined with the surgical procedure to 
predict the odds of a patient having 15 different adverse outcomes in the 30 days following 
surgery (UpToDate, 2016).  
The RCRI is more specific to predicting cardiac complications including specifically 
myocardial infarction.  The RCRI predicts this risk based on six factors: high risk surgery 
(intraperitoneal, intrathoracic, vascular or suprainguinal), history of ischemic heart disease, 
history of congestive heart failure, history of cerebral vascular accident, pre-operative treatment 
with insulin and pre-operative creatinine of  >2mg/dl (UpToDate, 2016).  Using the RCRI, the 
patient in this case study, would have received only one point (for high risk surgery) which 
translates to a 0.9% risk of a major cardiac event (UpToDate, 2016).  According to the 
perioperative cardiac assessment algorithm, because this patient’s risk was <1%, no further 
testing was needed. If her risk had been >1%, the next step would have taken into consideration 
her METs <4 (ACC/AHA, 2014).  MET, or metabolic equivalent of the task, is an assessment of 
functional capacity or O2 consumption with activity. The ability to perform activities requiring 4 
METs or more (such as climbing a flight of stairs or walking at >4mph) indicates good 
functional capacity. Perioperative cardiac risk can be increased with a METs <4 (Hines & 
Marschall, 2008).  Like the patient in this case study, MET level can also be influenced by an 
underlying medical condition limiting their activity, so assessment of this can be inaccurate or 
nonspecific (similar to a patient with orthopedic problems).  
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Myocardial Ischemia  
 Myocardial ischemia can happen anytime that myocardial oxygen demand exceeds 
coronary artery blood flow or oxygen supply (Morgan & Mikhail, 2013).  This can be caused by 
atherosclerosis of the coronary arteries, thrombosis, severe hypertension or hypotension, 
tachycardia, hypoxemia, anemia or severe valvular disease (Morgan & Mikhail, 2013). 
Atherosclerosis is the most common cause of ischemia and is now being recognized as an 
inflammatory disease (Hines & Marschall, 2008).  The multiple risk factors as stated above lead 
to the development of atherosclerotic plaque, which is made up of inflammatory cells. These 
plaques can be vulnerable to rupture due to their lipid core and thin fibrous caps (Hines & 
Marschall, 2008). When they rupture a cascade of events including platelet aggregation, 
activation and vasoconstriction can lead to complete coronary obstruction and thus myocardial 
infarction (Hines & Marschall, 2008).  In the operating room, myocardial ischemia could be due 
to either an inflammatory response or a neuroendocrine stress response (Hines & Marschall, 
2008).  Surgery itself can create a pro-thrombotic environment, leading to decreased oxygen 
delivery similar to the plaque rupture described above.  Catecholamine release can lead to 
tachycardia and hypertension that can both increase the propensity for plaque rupture but also 
increase the oxygen demand in a patient with an already compromised myocardial supply (Hines 
& Marschall, 2008).  
 Signs & Symptoms  
 The most common symptom of myocardial ischemia is angina. When the myocardium is 
ischemic it releases adenosine and bradykinin which stimulates the receptors of the thoracic 
sympathetic and somatic nerve fibers in the spinal cord that result in angina (Hines & Marschall, 
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2008).  Angina can also radiate to the left arm, shoulder, neck or jaw. Other symptoms can 
include shortness of breath, epigastric pain, nausea or diaphoresis.  In some patients, especially 
with a history of diabetes, there can be no symptoms at all (Hines & Marschall, 2008). Having 
the patient anesthetized in the operating room, complicates the early diagnosis of myocardial 
ischemia because they are unable to verbalize their symptoms. Some secondary signs that may 
be noticeable with perioperative monitoring include slow atrioventricular nodal conduction and 
hypotension due to decreased contractility (Hines & Marschall, 2008).  Unfortunately, these are 
very non-specific signs, which can also be contributed to the anesthetics themselves. Tachycardia 
has been found to precede myocardial ischemia in many cases, due to the increased oxygen 
demand, and thus its presence can be a sign to the anesthetist to watch for ischemic changes on 
the ECG (Landesberg, 1993; Landesberg, 2001).   
Cardiac Monitoring  
Transesophageal Echocardiography (TEE) 
Echocardiography can be used to identify myocardial ischemia through the detection and 
localization of regional wall motion abnormalities (RWMA) (Nagelhout & Plaus, 2014).  When 
a segment of the myocardium is experiencing a perfusion deficit, that segment has less 
thickening and motion towards the center of the ventricle than normal, which is called 
hypokinesis (Shanewise, 2006).   This can happen within one minute of a perfusion deficit, thus 
making it a more sensitive monitor than ST segment changes (Shanewise, 2006).  RWMA can be 
caused by other factors than ischemia, including conduction abnormalities, sudden changes in 
preload or afterload and severe dysfunction of the right ventricle (Nagelhout & Plaus, 2014).  
Although it is more sensitive than ECG, there are several limitations to its use.  These include its 
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cost effectiveness in non-cardiac operations, it requires the anesthetist to have specific training in 
its use for proficiency, it is not practical for use in a continuous fashion like ECG, it can only 
visualize a small portion of the ventricle in a single view thus possibly missing ischemia in a 
non-visualized area and its use is limited to the period of time while intubated thus missing the 
critical time for ischemia during induction and emergence (Shanewise, 2006)(ACC/AHA, 2007).  
The 2014 ACC/AHA perioperative guidelines state, “the routine use of intraoperative 
echocardiogram during non-cardiac surgery to screen for cardiac abnormalities or to monitor for 
myocardial ischemia is not recommended in patients without risk factors or procedural risk for 
significant hemodynamic, pulmonary or neurological compromise”.  
Pulmonary Capillary Wedge Pressures (PCWP) 
 Pulmonary artery catheterization can be used to monitor for intra-operative myocardial 
ischemia by measuring trends of the pulmonary artery wedge pressures (Nagelhout & Plaus, 
2014).  If the left ventricle function was to become impaired, there could be an increase in left 
ventricular end diastolic pressures (LVEDP), as indirectly measured by the pulmonary artery 
wedge pressure (Nagelhout & Plaus, 2014).  Because LVEDP is only indirectly measured, other 
factors can falsely influence its trend including: mitral stenosis, COPD, increased pulmonary 
vascular resistance, and location of the catheter in the lung (Shanewise, 2006). Thus studies have 
concluded that PCWP does not have good sensitivity or specificity for detecting myocardial 
ischemia (Shanewise, 2006).  It is also an invasive procedure that can have serious complications 
and requires the anesthetist to have knowledge and experience in interpreting its results 
(Nagelhout & Plaus, 2014).  The 2014 ACC/AHA guidelines state that the use of pulmonary 
artery catheters may aid in the hemodynamic management of an already critically ill patient 
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undergoing surgery but that its routine use, even with patients with elevated risk, is not 
recommended.  
ST Segment 
The ST segment of the ECG is measured from the J point (the point at which the QRS 
segment ends and the ST segment begins) and ends at the beginning of the T wave (Nagelhout & 
Plaus, 2014).  This segment should be isoelectric (or flat) as it represents when ventricular cells 
are in the plateau phase after depolarization and there is no electrical conduction (Nagelhout & 
Plaus, 2014). Ischemic or damaged tissue causes the cells of the myocardium to react 
abnormally.  An ST segment that is depressed is indicative of myocardial ischemia due to either 
increased oxygen demand or limited coronary blood flow (Hines & Marschall, 2008).  If the ST 
segment is elevated, there is total occlusion of a coronary artery, leading to a myocardial 
infarction (Hine & Marschall, 2008).  When calculating the ST segment for deviation, it is 
compared to the preceding PR segment as an isoelectric reference (Nagelhout & Plaus, 2014).  
 There are differing opinions on where the ST segment should start being assessed.  Some 
literature/manufacturers measure the ST segment starting at the J point, and some start 60 or 80 
milliseconds from the J point (Nagelhout & Plaus, 2014). This debate will not be reviewed in this 
discussion.  When the ECG is first connected to the patient, a baseline of the ST segment is 
established per the manufacturer’s analysis algorithm or a baseline can be set manually by the 
anesthetist (Drew et al., 2004). From this point on, subsequent ST segments will be compared to 
this baseline and displayed on the monitor as a positive or negative numerical value.  Alarm 
parameters are generally set to notify the anesthetist if the ST segment were to change 1 to 2mm 
above or below the baseline, as this is generally considered significant (Drew et al., 2004).  
Clinical implications of this include: discharging the previous patient from the monitor prior to 
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re-establishing an ECG so that the previous patient’s ST segment baseline is not used for 
comparison, changing the position of an ECG electrode after baseline is established can produce 
false alarms because of the change in deflection, and a change in body position can alter ST 
segments, mimicking ischemia. If possible obtain the baseline ECG in the side-lying surgical 
position prior to induction (AACN, 2016).  Patients that have a previously documented left 
bundle branch block or have a ventricular paced rhythm are generally not candidates for 
continuous ST segment monitoring because the nature of their ST segment is already steeply 
sloped which leads to frequent false alarms (Drew et al., 2004). 
Lead Placement 
 In the operating room, either a 3-lead or a 5-lead ECG is used for monitoring. For this 
discussion, we will focus on the 5-lead ECG, as there is increased sensitivity in the identification 
of myocardial ischemia when multiple leads are monitored (Nagelhout & Plaus, 2014).  A 5-lead 
ECG, as the name indicates, involves five ECG electrodes. It allows the anesthetist to monitor 
seven “views” of the heart.  Even though the monitor only displays a continuous ECG waveform 
for two leads, it is monitoring the ST segments of all seven “views” (Drew et al., 2004). 
Limb lead placement and corresponding areas of surveillance 
There are four limb electrodes-the white electrode is placed on the right side of the upper 
chest under the clavicle, the green electrode can be placed in any convenient location on the right 
side of the trunk, the black electrode is placed on the left side of the upper chest under the 
clavicle and the red is placed on the lower left side of the flank in the anterior axillary line 
(Nagelhout & Plaus, 2014).  These four electrodes placed on the perimeter of the chest, allow for 
the monitoring of six limb leads- I, II, III, AVL, AVR and AVF (Drew et al., 2004).  Leads I and 
ST SEGMENT MONITORING IN THE OR  15 
AVL monitor the lateral wall of the myocardium that corresponds with the circumflex 
distribution of coronary blood flow.  Leads II, III and AVF monitor the inferior wall that 
corresponds with the right coronary artery.  AVR is generally not used as a diagnostic lead 
(AACN, 2016).   
Precordial lead placement and corresponding area of surveillance 
The fifth electrode is placed in one of the six precordial positions, and its position 
determines the anatomical area of the heart being monitored (Drew et al., 2004).  Correct 
placement of these precordial leads is important because inaccurate placement can change the 
deflection of the waveform and potentially delay the sensitivity of that lead in the detection of ST 
segment changes (Drew et al., 2004).  For the patient that has pre- or intra-operative ST segment 
changes and is going to be monitored in the post-operative period for ischemia, marking the 
location of the electrodes with indelible ink to ensure replacement of the patches to the same 
location is imperative as relocating as little as 1 cm away from its original location can lead to 
waveform changes (AACN, 2016).  
 Placement of the electrode for lead V1 is in the fourth intercostal space, right of the 
sternal border. Lead V2 is placed in the fourth intercostal space, left of the sternal border. V1 and 
V2 are monitoring the septal wall and the distribution of the left anterior descending coronary 
artery. ST depression in V1-2 can also be a reciprocal change that reflects posterior infarction 
related to the right coronary artery or the circumflex. Lead V3 is placed equal distance between 
V2 and V4.  Lead V4 is placed in the midclavicular line at the fifth intercostal space.  Leads V3 
and V4 monitor the anterior wall of the myocardium supplied by the left anterior descending 
artery. The V5 electrode is placed horizontal to V4 on the anterior axillary line, half way 
between V4 and V6. V6 is placed horizontal to V5 on the mid-axillary line. V5 and V6, along 
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with leads I and AVL, monitor the lateral wall supplied by the circumflex artery (Nagelhout & 
Plaus, 2014; AACN, 2016).   
Lead Selection 
 The choice of what ECG leads to monitor the patient during the perioperative period is 
based on their history and pre-operative 12-lead ECG.  As previously discussed, the four limb 
leads will always allow for continuous ST segment monitoring of leads I, II, III, AVF, AVR and 
AVL (Drew et al., 2004).  So the decision left to be made is, which precordial (or V lead) is going 
to show the earliest ST segment changes specific to this patient and their history.  Improper 
selection of this V lead can lead to unrecognized myocardial ischemia or infarction (Nagelhout & 
Plaus, 2014).  If the patient has a pre-operative 12-lead that has ST segment changes in a specific 
lead, known as the ST fingerprint, than that lead should be monitored throughout the case. An ST 
fingerprint is a pattern of ST segment elevation or depression that is unique to a specific patient 
(AACN, 2016).  Also if the patient has known coronary artery disease in a specific vessel, or recent 
coronary intervention, the leads selected should correspond with that coronary artery distribution 
(AACN, 2016).  
 The debate and change in practice comes in with patients that do not have documented 
coronary artery disease or a remarkable pre-operative 12-lead ECG.  A systematic review of 
studies completed in the 1980-1990s and published in the Best Practice and Research of Clinical 
Anesthesiology, addressed the topic of monitoring for myocardial ischemia. This review was a 
synthesis of eighteen studies that addressed multiple topics related to perioperative ischemia and 
postoperative cardiac complications (Landesberg, 2005). One of the topics was continuous 12-lead 
ECG monitoring and lead sensitivity.  At the time, and interestingly still used commonly today, 
lead II and V5 were primarily monitored in the OR and detected only 80% of significant ST 
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changes (Landesberg, 2005). These studies were based on information gained from Holter 
monitoring in the outpatient setting to detect demand ischemia and they used absolute versus 
relative ST segment deviation (Landesberg, 2005).  More recently, with the advancement of 
automated ST segment monitoring algorithms, studies have been completed during the 
intraoperative and postoperative periods using continuous 12-lead ECGs to determine the most 
sensitive leads for ischemia.  In a landmark 2002 study, 185 patients undergoing vascular surgery 
were monitored in this fashion, with ischemia defined as ST segment deviation of 2mm in one lead 
or 1mm in two contiguous leads from the patient’s preoperative baseline (Landesberg, Mosseri, 
Wolf, Vesselov, & Weissman, 2002).  Post-operative infarction was defined by an elevation in 
troponin I levels. Of the 185 patients, 38 had transient ischemic events (ST depression) with 12 of 
those patients sustaining postoperative myocardial infarctions (Landesberg et al., 2002).   It was 
found that lead V3 most frequently (86.6%) demonstrated ischemia and was the earliest to show 
changes, followed by V4 (78.9%) and V5 (65.8%). For the patients that suffered myocardial 
infarction, V4 was the most sensitive and the earliest in detecting ischemia (83.3%), followed by 
V3 and V5 (75% each) (Landesberg et al., 2002).  The overall sensitivity in the detection of 
ischemia was 94.7% when either V3 or V4 was combined with the limb leads, compared to 76.3% 
when V5 was combined with the limb leads (Landesberg et al., 2002).  
 In 2005, a council of experts in Cardiology, Electrophysiology and Critical Care Nursing 
came to together to author the first formal standard for electrocardiographic monitoring in the 
hospital setting (Drew & Funk, 2006).  From these practice standards the ACC/AHA derived 
guidelines for intraoperative ST segment monitoring in patient’s undergoing non-cardiac surgery 
and recommend the use of V4 rather than V5 for the early detection of ischemia (2007). In 2008, 
the American Association of Critical Care Nurses published a practice-alert on ST-segment 
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monitoring for all patients in the Intensive Care Unit at risk for demand ischemia (this included 
weaning from the ventilator). This practice-alert was based on a systematic review of literature on 
ST segment monitoring (Fox, Kirkendall & Craney, 2010).   
 As related to lead selection, leads V3 and III were found to be the most sensitive in 
detecting ischemia especially for patients with a cardiac history or numerous risk factors (Fox, 
Kirkendall & Craney, 2010).  However the author stressed the importance of monitoring in a 
patient’s “fingerprint” lead if they have had a previously documented ST segment change, as it 
will be the most sensitive lead in their case (Fox, Kirkendall & Craney, 2010).  Of the limb leads, 
lead III has been found to be the most sensitive in detecting ischemia (Drew & Tisdale, 1993) 
(Flanders, 2007). As lead III is a limb lead that is continuously being monitored by the monitor’s 
algorithm, this is not of as much importance as lead selection for chest leads.  Lead II is more 
useful to have continually displayed for arrhythmia detection, especially atrial.  The anesthetist  
needs to be aware of the numerical changes in lead III for ST segment deviation and have the 
appropriate alarms set (Flanders, 2007).  
There are monitoring systems that can do continuous ST segment monitoring of all 12-
leads from a five electrode ECG system.  This is called a derived 12-lead or EASI. The five 
electrodes are placed in a specific configuration on the chest and allow for a more comprehensive 
assessment of the myocardium.  Monitoring more than one V lead simultaneously, increases the 
sensitivity of ischemia detection from roughly 85% to 96% (Shanewise, 2006) (Landesberg, 2002).  
The use of this derived 12-lead also eliminates the need for the anesthetist to make a decision 
regarding the most appropriate chest lead.  This type of monitoring is not equivalent to a 12-lead 
ECG but can closely correspond if used appropriately (AACN, 2016).  
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Perioperative myocardial infarction and ECG monitoring 
 As discussed earlier, perioperative myocardial infarction (PMI) can occur from either 
plaque rupture leading to acute coronary syndrome or from an imbalance in oxygen supply and 
demand (Landesberg et al, 2009).  Studies from the 1990s and 2000s found common similarities 
among patients who suffered PMI. They found a strong association between long duration (>20 
minutes) ST segment depression and progression to postoperative complications including 
myocardial infarction and death (Landesberg, 1993; Landesberg, 2001; Landesberg, 2009).  In 
these studies, perioperative cardiac events were rarely (<2%) or never, preceded by ST segment 
elevation (Landesberg, 1993; Landesberg, 2001). The longer the duration of ST segment 
depression, the higher the postoperative trend of troponin levels (Landesberg, 2001). To note, these 
studies were completed on high risk patients undergoing vascular surgery.  Another similarity in 
the studies was that each episode of ST segment depression was preceded by tachycardia from the 
patient’s baseline (ranging from 90-120bpm).  In the 2001 Landesberg study, patients were 
monitored using 12-lead ECG prior to induction through 72 hours post-operatively.  According to 
this study, “twenty-six (68%) of all the longest ischemic events started during the period between 
50 min before and 60 min after the end of surgery, during emergence from anesthesia (a time 
characterized by an increase in heart rate, blood pressure, sympathetic discharge and pro-coagulant 
activity). In eight (67%) of the patients with PMI, the longest ischemic episodes started within the 
same time period” (Landesberg, 2001, p.1842, 1843). None of the patients had significant ischemia 
(defined as less than 10minutes) during induction (Landesberg, 2001). Landesberg’s prior study 
in 1993 highlighted a similar connection between ST depression and tachycardia, but this study 
found that the majority of “long duration” ST depression occurred in the postoperative period but 
shorter episodes were identified during high demand, low supply periods in the OR (intubation, 
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emergence and extubation).  Both studies noted that the ST depression was transient in all episodes, 
highlighting the importance of continuous ST segment monitoring (Landesberg, 1993; 
Landesberg, 2001).   
Although further studies are needed to identify if early detection would reduce the mortality 
associated with perioperative myocardial ischemia- a few highlights can be identified regarding 
intraoperative monitoring. The importance of preventing and having a low threshold for treatment 
of tachycardia is essential.  As the episodes of ST depression were transient, choosing the most 
sensitive leads for its detection, will allow the anesthetist to identify that patient’s specific 
fingerprint leads that show ischemia during periods of high demand and low supply. This early 
detection may allow the anesthetist to more aggressively reverse the cause of ischemia, limiting 
the time of ST depression and hopefully decreasing the incidence of post-operative myocardial 
complications. Identification of which leads the patient typically has been showing ST segment 
depression could also translate into consistency across the phases of care into the post-operative 
period in the early detection of myocardial ischemia.  
Case Study Review 
 In retrospect, the case study discussed previously was a good example of a typical patient 
with increased risk factors for heart disease (age, hypertension, type 2 diabetes and 
hyperlipidemia) but based on cardiac preoperative evaluation was only deemed low to 
intermediate risk.  Her preoperative ECG was noncontributory but her METs less than 4 due to 
fatigue was concerning.  The ability to do continuous ST segment monitoring in the operating 
room was a valuable, simple and cost effective tool for this patient.  Assuring that the ECG 
patches were placed in the appropriate positions for the most accurate data, establishing a 
baseline for the J point, identifying that the ST segment alarms were on and set to alarm with 
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1mm of elevation or depression were important steps in correctly monitoring for ST segment 
changes.  Printing an ECG strip prior to induction is also a good practice for reference of the 
baseline throughout the case. The accuracy of these steps was confirmed by the literature 
reviewed in this Independent Project.  
A highlighted area for improvement though was the selection of V5 for the chest lead.  
The evidence suggests that monitoring the patient in V5 is based on outdated literature and is not 
the most sensitive chest lead in the detection of ST segment changes. Since this patient did not 
have documented coronary artery disease, V4 would have been the more appropriate and 
sensitive chest lead for monitoring.  Of the limb leads, lead III would show the earliest ST 
segment changes.  It is still appropriate to display lead II, as the monitor will alarm automatically 
if there is deviation of 1mm in lead III without it being continuously displayed.  The literature 
also highlighted the importance of accurate placement of ECG patches, especially the brown 
patch, as its placement is what directly dictates the chest lead being monitored, and thus the 
sensitivity to early ST segment changes.  The patient did face a potential imbalance in her 
oxygen supply versus demand due to the increased blood loss but with timely replacement of her 
volume status with a combination of crystalloid, colloid and red blood cells her vital signs 
remained stable without any significant change in her ST segments from baseline. She also did 
not experience any episodes of tachycardia throughout the case, which the literature found to 
precede most incidence of ST segment depression.  Again, the use of continuous ST segment 
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Conclusion 
 Although the incidence of intraoperative myocardial infarction is low, the mortality and 
costs associated with the adverse outcomes are high. As a large portion of our population ages, 
patients have more risk factors for heart disease and surgical options for treatment become more 
common, there is reason for the anesthetist to remain vigilant in the early recognition and 
possible reversal of myocardial ischemia during surgery.  Changes in the ST segment of the ECG 
correlate with myocardial ischemia or infarction.  Continuous ST segment monitoring on the 
ECG is a simple, cost effective and generally available tool for early recognition. Like most 
monitoring devices, it is essential that the anesthetist be knowledgeable in its use to provide the 
most accurate data.  Evidence highlights the importance of accurate ECG patch placement, lead 
selection, establishment of baseline and setting appropriate audible alarms to ensure the earliest 
recognition of ST segment changes.  Our anesthetic plan and early treatment during periods of 
imbalance in myocardial oxygen demand and supply was crucial in the avoidance of ischemia.  
The evidence provided in this Independent Project will educate anesthesia providers in the 
accurate use of continuous ST segment monitoring, thus providing their patients with the safest 
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